Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward S Kim

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 3, 2009
Epidermal growth factor receptor as a target in cancer therapyEdward S Kim
Clinical Advances in Hematology & Oncology : H&O|July 21, 2023
Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: lung cancerEdward S Kim
Cancer Journal (Sudbury, Mass.)|November 18, 2025
Decoding Destiny: Can We Deliver Artificial Intelligence-Powered Patient-centered Care?Edward S Kim
Translational Lung Cancer Research|December 3, 2015
Lung cancer diagnostics and treatments 2015: a renaissance of patient careEdward S Kim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
The Future of Molecular Medicine: Biomarkers, BATTLEs, and Big DataEdward S Kim
Clinical Lung Cancer|January 11, 2005
Cetuximab as a single agent or in combination with chemotherapy in lung cancerEdward S Kim
Nature Clinical Practice. Oncology|December 20, 2008
Lessons learned from lung cancer chemoprevention trialsEdward S Kim
Future Oncology (London, England)|August 8, 2022
Plain language summary of outcomes in people treated for lung squamous cell cancer with afatinib after receiving pembrolizumab with chemotherapyEdward S Kim
JCO Oncology Practice|November 12, 2024
How to Keep Up With Molecular Testing and Targeted Therapies in Lung CancerJyoti Malhotra, Edward S Kim
Therapeutic Advances in Drug Safety|August 2, 2014
Risks and benefits with bevacizumab: evidence and clinical implicationsCarla Kurkjian, Edward S Kim
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Journal of the National Comprehensive Cancer Network : JNCCN|October 3, 2009
Epidermal growth factor receptor as a target in cancer therapyEdward S Kim
Clinical Advances in Hematology & Oncology : H&O|July 21, 2023
Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: lung cancerEdward S Kim
Cancer Journal (Sudbury, Mass.)|November 18, 2025
Decoding Destiny: Can We Deliver Artificial Intelligence-Powered Patient-centered Care?Edward S Kim
Translational Lung Cancer Research|December 3, 2015
Lung cancer diagnostics and treatments 2015: a renaissance of patient careEdward S Kim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
The Future of Molecular Medicine: Biomarkers, BATTLEs, and Big DataEdward S Kim
Clinical Lung Cancer|January 11, 2005
Cetuximab as a single agent or in combination with chemotherapy in lung cancerEdward S Kim
Nature Clinical Practice. Oncology|December 20, 2008
Lessons learned from lung cancer chemoprevention trialsEdward S Kim
Future Oncology (London, England)|August 8, 2022
Plain language summary of outcomes in people treated for lung squamous cell cancer with afatinib after receiving pembrolizumab with chemotherapyEdward S Kim
JCO Oncology Practice|November 12, 2024
How to Keep Up With Molecular Testing and Targeted Therapies in Lung CancerJyoti Malhotra, Edward S Kim
Therapeutic Advances in Drug Safety|August 2, 2014
Risks and benefits with bevacizumab: evidence and clinical implicationsCarla Kurkjian, Edward S Kim
Pageof 19